Mode
Text Size
Log in / Sign up

Respiratory Failure

Subtypes of Respiratory Failure

Airway Obstruction 3 Chronic hypercapnic respiratory failure 1 Nasal obstruction 1 Respiratory failure requiring mechanical ventilation 1

16 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Respiratory Failure

65 trials tracked for Respiratory Failure: 6 in phase 3 or 4 and 5 with published results. The most-cited published study has 121 citations.

65Trials tracked
6Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 3 Phase 3 3 Phase 2 9 Phase 1 2 Other / NA 48
  1. Phase 4 Preventing Cardiovascular collaPse With Administration of Fluid Resuscitation Before Endotracheal Intubation Completed · 121 cited
  2. Phase 3 Astral VAPS AutoEPAP Clinical Trial Completed · 40 cited
  3. Phase 4 Randomized Trial of Sedative Choice for Intubation Completed · 27 cited
  4. Phase 3 Heart And Lung Failure - Pediatric INsulin Titration Trial Completed · 25 cited
  5. Phase 3 Self-management of Sedative Therapy by Ventilated Patients Completed · 4 cited
  6. Phase 4 Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure Completed
Show 44 more trials
  1. Phase 2 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection Completed
  2. Phase 2 Nebulized Hypertonic Saline for Mechanically Ventilated Children Completed
  3. Phase 2 Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients Completed
  4. Phase 2 Tenecteplase in Patients With COVID-19 Completed
  5. Phase 2 The Effect of Thiamine vs. Placebo on VO2 in Critical Illness Completed
  6. Phase 2 Efficacy and Safety of Dexmedetomidine During Non-Invasive Positive Pressure Ventilation Completed
  7. Phase 2 Vitamin D in Ventilated ICU Patients Completed
  8. Phase 2 Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure Completed
  9. Phase 2 Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery Completed
  10. Phase 1 Novel Arm Restraint in the Intensive Care Unit Completed
  11. Phase 1 Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB With Rectus Sheath Block (RSB) in Cardiac Surgery Completed
  12. N/A DirEct Versus VIdeo LaryngosCopE Trial Completed
  13. N/A Extubation With or Without Spontaneous Breathing Trial Completed
  14. N/A Non-invasive Ventilation vs Oxygen Therapy After Extubation Failure Completed
  15. N/A Efficiency of the King Vision Video Laryngoscope Completed
  16. N/A Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors Completed
  17. N/A Impact of Early Enteral vs. Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines Completed
  18. N/A Protocolized Post-Extubation Respiratory Support Study Completed
  19. N/A Comparison Between Two Methods of Spontaneous Breathing Trial (SBT) Completed
  20. N/A Extubation Readiness and Neuroventilatory Efficiency After Acute Respiratory Failure Completed
  21. N/A Safety and Efficacy of Endotracheal Intubation Using Glidescope Video-Laryngoscope Completed
  22. N/A Third International Study on Mechanical Ventilation Completed
  23. N/A The Emergency Department Sedation Pilot Trial Completed
  24. N/A Trilogy Comparison Study - Pediatrics Completed
  25. N/A Bougie Use in Emergency Airway Management Completed
  26. N/A Pragmatic Trial Examining Oxygenation Prior to Intubation Completed
  27. N/A Treatment of Critical Illness Polyneuromyopathy Completed
  28. N/A Implementation of Nudges to Promote Utilization of Low Tidal Volume Ventilation (INPUT) Study Completed
  29. N/A Novel Non-Invasive Monitoring Parameter in a Hospital Setting Completed
  30. N/A Sleep and Circadian Rhythms in Mechanically Ventilated Patients Completed
  31. N/A Mode Of Ventilation During Critical IllnEss Pilot Trial Completed
  32. N/A Therapeutic Plasma Exchange Followed by Convalescent Plasma Transfusion in Severe and Critically Ill COVID-19 Patients Completed
  33. N/A Assessing Ventilator Safety in Patients on Pressure-Support Ventilation Completed
  34. N/A Multi-center Evaluation of the NEMO Gauge to Aid in Correct Positioning of the Endotracheal Tube Completed
  35. N/A Pilot Study of High-flow Humidified Nasal Oxygen During Breaks From Noninvasive Ventilation Completed
  36. N/A Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis Completed
  37. N/A Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins Completed
  38. N/A Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDS Completed
  39. N/A Metabolites of Tramadol in the Postoperative Surgical Patients Completed
  40. N/A Electrical Stimulation in Patients With Prolonged Mechanical Ventilation Completed
  41. N/A External Nasal Dilator and Oxygen Therapy in Respiratory Failure Completed
  42. N/A A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU Completed
  43. N/A Pragmatic Investigation of optimaL Oxygen Targets Trial Completed
  44. N/A Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness Completed

Showing the 50 most-cited and recently-updated of 65 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Respiratory Failure: what the trials found

Ketamine is established as a treatment option for respiratory failure 1.

The use of Astral was associated with a statistically significant reduction in the Oxygen Desaturation Index 4% (ODI4%) compared to standard care (3.16 vs 7.61; p=0.0134) 7.

Dexmedetomidine has been shown to significantly reduce the duration of mechanical ventilatory support after study enrollment (68.7 vs 50.3; p=0.02), while it did not significantly impact anxiety ratings or the incidence of delirium 9. Additionally, dexmedetomidine was associated with a specific aggregate sedative exposure during use 13 and showed no significant difference in NIV tolerance scores or Riker-SAS score distribution 18.

Intravenous crystalloid fluid (500 mL) was evaluated for its impact on ventilator-free days (20; 19) and ICU-free days (16; 14) 5. Insulin administration resulted in comparable outcomes for ICU-free days (20; 19.4) and ventilator-free days (21.8; 20.9), with a low incidence of severe hypoglycemia 8.

Propofol did not show statistically significant differences in the duration of mechanical ventilation, MICU stay, or vasopressor support 6.

Recent results — preliminary, needs further review

  • Volume Control mode was evaluated for ventilator-free days (VFDs) to Day 28 2.
  • Enteral nutrition and electroencephalography were investigated in recent trials [3, 4].
  • A rectus sheath block with bupivacaine was assessed regarding post-extubation pain scores and quality of recovery 19.
  • The Viasys Avea Ventilator was evaluated for ventilator-free days 21.

For the clinician treating this condition

  • Dexmedetomidine significantly reduces the duration of mechanical ventilatory support in patients with respiratory failure.
  • Astral intervention is associated with a significant reduction in Oxygen Desaturation Index (ODI4%).
  • Ketamine, intravenous crystalloid fluids, and insulin are established interventions within the clinical context of respiratory failure.

AI synthesis of 11 cited trials, updated Jun 25, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Respiratory Failure

Does continuous monitoring of heart rate and oxygen saturation help premature infants with respiratory problems?

Yes, continuous monitoring of heart rate and oxygen saturation is standard for premature infants with respiratory problems, as it helps detect deterioration early and guide treatment.

Full answer →
What causes respiratory failure in a male neonate with X-linked centronuclear myopathy?

Respiratory failure in a male neonate with X-linked centronuclear myopathy is caused by severe muscle weakness from MTM1 gene mutations, leading to inadequate breathing and ventilator dependence.

Full answer →

All Respiratory Failure Articles